Hong Kong bourse rejects Akeso IPO filing
Hong Kong’s stock exchange has returned Chinese biotechnology firm Akeso’s listing application, a deal being sponsored by JP Morgan and Morgan Stanley.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: